Related Experiment Video

Updated: Aug 30, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

[Metabolic disease or shaken baby syndrome?]

Lisbeth Samsø Schmidt1, Jens Erik Klint Nielsen, Susanne Stilling Blichfeldt

  • 1RAS Paediatrisk afdeling, Epilepsihospitalet i Dianalund.

Ugeskrift for Laeger
|October 9, 2003
PubMed

Insights

Late diagnosis of glutaricacidaemia type 1 in children can occur due to initial misdiagnosis of subdural hematoma as shaken baby syndrome. This highlights the importance of considering metabolic disorders in pediatric cases.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Neurology

Background:

  • Glutaricacidaemia type 1 (GA1) is a rare inherited metabolic disorder affecting neurotransmitter metabolism.
  • Subdural hematoma is a serious condition often associated with traumatic brain injury, including abusive head trauma like shaken baby syndrome.

Observation:

  • Two pediatric cases are presented where subdural hematoma was an initial clinical presentation.
  • Diagnosis of glutaricacidaemia type 1 was delayed in both cases.
  • The delay was attributed to the initial clinical suspicion of shaken baby syndrome.

Findings:

  • Glutaricacidaemia type 1 can manifest with neurological symptoms mimicking traumatic brain injury.
  • Subdural hematoma can be a presenting sign of GA1, leading to potential misdiagnosis.
  • Early recognition of metabolic disorders is crucial for timely intervention.

Implications:

  • This case series underscores the necessity of including metabolic screening in the differential diagnosis of subdural hematoma in children, especially when the clinical context is ambiguous.
  • Increased awareness among clinicians can prevent diagnostic delays and improve outcomes for children with GA1.
  • Highlights the critical role of biochemical testing in pediatric neurology to identify treatable metabolic encephalopathies.

More Related Videos

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice09:13

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice

Published on: July 11, 2025

Related Concept Videos

Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...